The Role of Nerve Blocks in Hip Arthroscopy
Launched by COLUMBIA UNIVERSITY · Apr 23, 2018
Trial Information
Current as of June 15, 2025
Withdrawn
Keywords
ClinConnect Summary
The popularity of arthroscopic hip surgery has increased greatly over the last 10 years, particularly for correcting Femoroacetabular Impingement (FAI). FAI is a structural abnormality of the proximal femur, the acetabulum, or both. It is a leading cause of labral tears in the hip joint and can cause cartilage damage, which may increase subsequent risk of developing osteoarthritis. Though far less invasive than open hip surgery such as for a total hip replacement, hip arthroscopy can cause significant postoperative pain for the patient. Given how relatively new the procedure still is, metho...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled to receive unilateral arthroscopy hip surgery at Columbia University Medical Center with Dr. Lynch.
- Exclusion Criteria:
- • Patients scheduled to receive bilaterally or staged hip arthroscopy.
- • Patients unwilling to participate in the research.
- • History of chronic opioid use.
- • Contraindication or allergy to study medications, such as QL block.
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Thomas S Lynch, M.D.
Principal Investigator
Columbia University Department of Orthopedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials